Country Medical Lead
LIsboa, PT
This role is considered Hybrid.
Summary
The Country Medical Lead will be responsible for all Medical Affairs activities in Portugal, supporting both marketed and pipeline products. This includes leadership across medical strategy, clinical development (especially Phase IV), scientific exchange, and cross-functional collaboration. A key member of the Country Leadership Team, the Country Medical Lead will act as the medical counterpart to the Country Manager/GM and serve as the primary liaison between local, regional, and global medical teams.
This role requires strong leadership, scientific acumen, and the ability to operate in a dynamic, cross-functional environment. Approximately 50% of the role involves field-based external engagement.
Job Description
Medical Strategy & Leadership
- Develop and implement the Country Medical Affairs Plan, aligned with global and regional strategies.
- Drive short- and long-term medical strategy to support product lifecycle, including pre-launch, launch, and post-marketing phases.
- Manage the country medical budget and contribute to business planning activities.
- Represent Medical Affairs on the Country Leadership Team and in cross-functional strategic forums.
Team Leadership & Development
- Lead, mentor, and develop direct report(s) to build strong scientific capabilities.
- Promote a culture of accountability, integrity, scientific excellence, and cross-functional collaboration.
- Identify talent development opportunities and ensure succession planning.
Scientific Engagement & Medical Excellence
- Build and maintain strong peer-to-peer relationships with key opinion leaders (KOLs), clinical investigators, and medical societies.
- Identify and support high-impact medical education initiatives, advisory boards, symposia, and scientific publications.
- Oversee medical input into brand planning and provide scientific guidance to internal stakeholders.
- Drive accurate, fair-balanced medical communication and scientific exchange with both internal and external audiences.
Clinical Research & Evidence Generation
- Provide input into local and regional clinical development strategies.
- Facilitate Phase IV and real-world evidence (RWE) studies, including registries and investigator-initiated studies (IIS).
- Ensure medical guidance on study feasibility, timelines, and alignment with global programs.
Compliance & Governance
- Ensure full compliance with internal policies, industry standards, and local regulatory requirements.
- Champion medical governance and uphold ethical conduct in all activities.
Qualifications
- Medical Doctor (M.D.), PhD, PharmD or equivalent advanced scientific qualification.
- Minimum of 15 years of industry experience, including significant leadership in Medical Affairs or related functions.
- Proven track record of people leadership and team development.
- Strong experience in rare diseases and/or biotechnology preferred.
- Deep understanding of the Portuguese regulatory and healthcare landscape.
- Fluent in Portuguese and business proficient in English.
- Ability to navigate complex matrix organizations and lead cross-functional initiatives.
- Strategic thinker with excellent problem-solving, communication, and decision-making skills.
- Comfortable operating with autonomy and agility in a fast-paced, evolving environment.
Key Skills and Compentencies
Additional Information
- Approximately 50% of time will be spent in the field engaging with external stakeholders.
- This role requires a curious, entrepreneurial mindset and a strong commitment to scientific excellence and collaboration.
About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.
Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.
At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.